| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V109007 | Ac-Glu-Asp(EDANS)-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Gly-Lys(DABCYL)-Glu-NH2 acetate | Ac-Glu-Asp(EDANS)-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Gly-Lys(DABCYL)-Glu-NH2 acetate is a cathepsin D substrate that can be used for the detection of cathepsin D FRET. | |
|
V129061 | Anti-inflammatory agent 113 | Anti-inflammatory agent 113 is a cathepsin L (CTSL) inhibitor with anti-inflammatory activity and a CTSL IC50 value of 5.52 μM. | |
|
V131137 | Cathepsin D degrader 1 | Cathepsin D degrader 1 is an orally effective anti-hepatic fibrosis compound that targets cathepsin D. | |
|
V101025 | Cathepsin K inhibitor 7 | Cathepsin K inhibitor 7 (Compound 7) is a Cathepsin K inhibitor with a pKi value of 7.3 for CatK. | |
|
V119350 | Cathepsin K-IN-8 | 501126-27-8 | Cathepsin K-IN-8 (Examples 6-60) is a cathepsin K inhibitor that can be used to study inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis, and tumors. |
|
V87358 | CTSL/CAPN1-IN-1 | CTSL/CAPN1-IN-1 (compound 14a) is an orally active CTSL and CAPN1 inhibitor with IC50 values of 3.34 nM and 375.1 nM, respectively. | |
|
V3413 | E-64 HCl | E-64 HCl, the hydrochloride salt form of E-64, which isisolated from cultures of Aspergillus, is anovel, potent,irreversible and selective cysteine protease inhibitor with IC50 of 9 nM for papain. | |
|
V86026 | GB111-NH2 hydrochloride | ||
|
V4301 | MK-0674 | 887781-62-6 | MK-0674 is a novel, potent, orally bioavailable and selectivecathepsin Kinhibitor with anIC50of 0.4 nM. |
|
V142684 | PI3K-001 | PI3K-001 is a prodrug and antifibrotic drug sensitive to cathepsin B. | |
|
V144470 | S2160 hydrochloride | 38789-84-3 | S2160 hydrochloride is a substrate for cathepsin B and can be used for the determination of cathepsin B by calorimetry. |
|
V88986 | SmCB1-IN-1 | SmCB1-IN-1 (Compound 2h) is an inhibitor of Schistosoma mansoni protease B1 (SmCB1) with Ki of 0.05 μM. | |
|
V104024 | TB-9 | 1415033-91-8 | TB-9 is a Tasiamide B derivative and a potent inhibitor of cathepsin D, cathepsin E, and BACE1 with IC50 of 0.0783 nM, 0.724 nM, and 54.2 nM, respectively. |
|
V146997 | VK13 | VK13 is a potent inhibitor of human cathepsin L (hCatL) with a Ki value of 0.55 nM, and also a potent inhibitor of SARS-CoV-2 3CLpro (3CL-PR) with a Ki value of 2.6 nM. | |
|
V147216 | Y1693 | 2812381-74-9 | Y1693 is an orally effective RANKL inhibitor with a Kd value of 5.03 μM for hRANKL. |
|
V147297 | Z-Arg-Lys-AOMK | 2810056-57-4 | Z-Arg-Lys-AOMK is a cathepsin B inhibitor that can cross the blood-brain barrier. |
|
V85555 | Z-FF-FMK (Z-Phe-Phe-FMK) | 105608-85-3 | |
|
V147421 | Z-Val-Val-Nle-diazomethylketone | 155026-49-6 | Z-Val-Val-Nle-diazomethylketone is a cathepsin S (CATS) inhibitor. |